Strados Labs is at the forefront of respiratory health innovation with its FDA-cleared RESP® Biosensor, a wearable stethoscope designed to monitor lung health effectively from hospital to home. This groundbreaking device continuously captures lung sounds, including coughs and wheezes, providing healthcare professionals with real-time data to enhance patient care. The accompanying Strados™ Mobile App and secure cloud storage ensure that valuable insights into patient symptoms are readily available for analysis, making it easier to manage conditions such as asthma, chronic cough, and COPD. With over 600,000 validated coughs and 19 million breaths captured across four continents, Strados Labs has established itself as a leader in digital lung acoustics.

Founded with the mission of making every breath count, Strados Labs emphasizes the importance of accurate and objective monitoring of lung function. By allowing patients to wear a discreet monitoring device throughout their daily activities, the technology reduces the burden on users while providing critical data that can significantly impact treatment outcomes and research in clinical trials. With ongoing partnerships in scientific studies—such as their collaboration with Lurie Children's Hospital—Strados Labs continues to expand its reach and improve respiratory health management through innovative technology.